Ultragenyx Pharmaceutical reported $21.85M in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US USD 5.84M 483K
Agios Pharmaceuticals AGIO:US USD 5.18M 1.12M
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Esperion Therapeutics ESPR:US USD 29.54M 313K
Insmed INSM:US USD 66.28M 741K
IONIS PHARMACEUT IONS:US USD 20.64M 834K
Karyopharm Therapeutics KPTI:US USD 4.25M 779K
Kyowa Hakko Kirin 4151:JP JPY 72.11B 4.11B
Macrogenics MGNX:US USD 1.09M 1.86M
Moderna Inc MRNA:US USD 2.08B 156M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Ptc Therapeutics PTCT:US USD 14.81M 192K
Puma Biotechnology PBYI:US USD 5.45M 1.21M
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Sarepta Therapeutics SRPT:US USD 221.19M 13.1M
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M